Pulmonary arterial hypertension in congenital heart disease: Eisenmenger's syndrome : a global perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783837422160
- Maße
-
25 cm
- Umfang
-
95 S.
- Ausgabe
-
1st ed.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Schlagwort
-
Eisenmenger-Syndrom
Herzkrankheit
Kardiologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Bremen, London, Boston, Mass.
- (wer)
-
UNI-MED-Verl.
- (wann)
-
2013
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:10 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- UNI-MED-Verl.
Entstanden
- 2013
Ähnliche Objekte (12)
Pulmonary arterial hypertension related to congenital heart disease
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Practical management of riociguat in patients with pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Pulmonary arterial hypertension related to congenital heart disease
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Practical management of riociguat in patients with pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Pulmonary arterial hypertension related to congenital heart disease
Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension
Phosphodiesterase 10A upregulation contributes to pulmonary arterial hypertension
Aberrant epigenetic landscape in human pulmonary arterial hypertension
Role of dimethylarginine dimethylaminohydrolases (DDAH) in pulmonary arterial hypertension
The Protective Role of PPARgamma in Pulmonary Arterial Hypertension
Quality of life and biomarkers in pulmonary arterial hypertension
Arterial hypertension
Practical management of riociguat in patients with pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Antifibrotic drugs: new candidates for the treatment of pulmonary arterial hypertension?